Published in Avicenna J Med Biotechnol on July 01, 2013
Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med (2001) 16.81
A thioredoxin gene fusion expression system that circumvents inclusion body formation in the E. coli cytoplasm. Biotechnology (N Y) (1993) 4.49
Parathyroid hormone secretion and action: evidence for discrete receptors for the carboxyl-terminal region and related biological actions of carboxyl- terminal ligands. Endocr Rev (2005) 1.58
Fusion tails for the recovery and purification of recombinant proteins. Protein Expr Purif (1992) 1.32
Crystal structure of human parathyroid hormone 1-34 at 0.9-A resolution. J Biol Chem (2000) 1.09
Human parathyroid hormone-(1-34) increases bone mass in ovariectomized and orchidectomized rats. Endocrinology (1988) 1.08
Infrequent delivery of a long-acting PTH-Fc fusion protein has potent anabolic effects on cortical and cancellous bone. J Bone Miner Res (2007) 1.05
Engineering of a Pichia pastoris expression system for secretion of high amounts of intact human parathyroid hormone. J Biotechnol (2005) 0.99
Metabolism of parathyroid hormone by Kupffer cells: analysis by reverse-phase high-performance liquid chromatography. Biochemistry (1982) 0.96
Parathyroid hormone induces protein kinase C but not adenylate cyclase in adult cardiomyocytes and regulates cyclic AMP levels via protein kinase C-dependent phosphodiesterase activity. Biochem J (1995) 0.91
Expression of human parathyroid hormone-(1-84) in Escherichia coli as a factor X-cleavable fusion protein. J Biol Chem (1990) 0.90
Daily treatment with human recombinant parathyroid hormone-(1-34), LY333334, for 1 year increases bone mass in ovariectomized monkeys. J Clin Endocrinol Metab (1999) 0.90
Extracellular production of human parathyroid hormone as a thioredoxin fusion form in Escherichia coli by chemical permeabilization combined with heat treatment. Biotechnol Prog (2005) 0.89
High-level production of recombinant human parathyroid hormone 1-34. Appl Environ Microbiol (1998) 0.89
A small dose of human parathyroid hormone(1-34) increased bone mass in the lumbar vertebrae in patients with senile osteoporosis. Miner Electrolyte Metab (1995) 0.86
Large scale preparation of recombinant human parathyroid hormone 1-84 from Escherichia coli. Protein Expr Purif (2007) 0.84
Human parathyroid hormone: efficient synthesis in Escherichia coli using a synthetic gene, purification and characterization. Int J Pept Protein Res (1994) 0.83
Stabilization of recombinant proteins from proteolytic degradation in Escherichia coli using a dual affinity fusion strategy. Biotechnol Appl Biochem (1991) 0.81
Expression of human parathyroid hormone in mammalian cells, Escherichia coli and Saccharomyces cerevisiae. J Biotechnol (1994) 0.80
Study on preparation and activity of a novel recombinant human parathyroid hormone(1-34) analog with N-terminal Pro-Pro extension. Regul Pept (2007) 0.80
Thrombin and H64A subtilisin cleavage of fusion proteins for preparation of human recombinant parathyroid hormone. J Protein Chem (1991) 0.79
Impacts of the N-terminal fragment analog of human parathyroid hormone on structure, composition and biomechanics of bone. Eur J Pharm Sci (2012) 0.78
A bioassay for parathyroid hormone and other substances affecting bone metabolism. Ir J Med Sci (1976) 0.78
Parathyroid hormone bioassay using human kidney cortical cells in primary culture. Acta Endocrinol (Copenh) (1982) 0.77
Genotype characterization and phylogenetic analysis of hepatitis B virus isolates from Iranian patients. J Med Virol (2005) 1.36
CD8+ T cells as a source of IFN-γ production in human cutaneous leishmaniasis. PLoS Negl Trop Dis (2010) 1.14
Complete genomic sequence and phylogenetic relatedness of hepatitis B virus isolates from Iran. J Med Virol (2005) 1.08
Hepatitis B virus genotyping, core promoter, and precore/core mutations among Afghan patients infected with hepatitis B: a preliminary report. J Med Virol (2006) 1.08
Leishmaniasis recidivans among school children in Bam, South-east Iran, 1994-2006. Int J Dermatol (2010) 1.06
Lacritin, a novel human tear glycoprotein, promotes sustained basal tearing and is well tolerated. Invest Ophthalmol Vis Sci (2011) 1.06
Clinical, virologic and phylogenetic features of hepatitis B infection in Iranian patients. World J Gastroenterol (2008) 1.04
Molecular analysis and phylogenetic characterization of HIV in Iran. J Med Virol (2006) 1.04
Immune response and protection assay of recombinant major surface glycoprotein of Leishmania (rgp63) reconstituted with liposomes in BALB/c mice. Vaccine (2006) 1.03
Expression of human tissue plasminogen activator in the trypanosomatid protozoan Leishmania tarentolae. Biotechnol Appl Biochem (2007) 0.97
Development of a recombinant Leishmania major strain sensitive to ganciclovir and 5-fluorocytosine for use as a live vaccine challenge in clinical trials. Vaccine (2005) 0.90
Do mutations in Plasmodium falciparum dihydropteroate synthase and dihydrofolate reductase confer resistance to sulfadoxine-pyrimethamine in Iran? Trans R Soc Trop Med Hyg (2002) 0.87
Evaluation the treatment outcomes of intracapsular femoral neck fractures with closed or open reduction and internal fixation by screw in 18-50-year-old patients in Isfahan from Nov 2010 to Nov 2011. Adv Biomed Res (2013) 0.87
Expression of a novel chimeric truncated t-PA in CHO cells based on in silico experiments. J Biomed Biotechnol (2010) 0.85
Frequency and genotype of GB virus C among Iranian patients infected with HIV. J Med Virol (2008) 0.85
A novel variant of t-PA resistant to plasminogen activator inhibitor-1; expression in CHO cells based on in silico experiments. BMB Rep (2011) 0.85
Targeting high affinity and epitope-distinct oligoclonal nanobodies to HER2 over-expressing tumor cells. Exp Cell Res (2012) 0.84
Combined TGE-SGE expression of novel PAI-1-resistant t-PA in CHO DG44 cells using orbitally shaking disposable bioreactors. J Microbiol Biotechnol (2011) 0.84
Prevalence of viral hepatitis and molecular analysis of HBV among voluntary blood donors in west Iran. New Microbiol (2009) 0.84
Molecular and phylogenetic analysis of human influenza virus among Iranian patients in Shiraz, Iran. J Med Virol (2007) 0.83
Genetically engineered T cells bearing chimeric nanoconstructed receptors harboring TAG-72-specific camelid single domain antibodies as targeting agents. Cancer Lett (2012) 0.82
Increased expression of recombinant human tissue plasminogen activator in Leishmania tarentolae. Biotechnol J (2010) 0.81
Frequency of hepatitis G virus infection among HIV positive subjects with parenteral and sexual exposure. J Gastrointestin Liver Dis (2008) 0.81
The role of liposome charge on immune response generated in BALB/c mice immunized with recombinant major surface glycoprotein of Leishmania (rgp63). Exp Parasitol (2009) 0.81
Cloning and expression of functional full-length human tissue plasminogen activator in Pichia pastoris. Appl Biochem Biotechnol (2010) 0.81
Molecular cloning of cDNA of mammalian and chicken II gonadotropin-releasing hormones (mGnRHs and cGnRH-II) in the beluga (Huso huso) and the disruptive effect of methylmercury on gene expression. Fish Physiol Biochem (2009) 0.80
Diagnosis and monitoring of human cytomegalovirus infection in bone marrow transplant recipients by quantitative competitive PCR. Exp Clin Transplant (2006) 0.80
The role of liposome size on the type of immune response induced in BALB/c mice against leishmaniasis: rgp63 as a model antigen. Exp Parasitol (2012) 0.80
Human Tissue Plasminogen Activator Expression in Escherichia coli using Cytoplasmic and Periplasmic Cumulative Power. Avicenna J Med Biotechnol (2010) 0.80
Enhancement of immune response and protection in BALB/c mice immunized with liposomal recombinant major surface glycoprotein of Leishmania (rgp63): the role of bilayer composition. Colloids Surf B Biointerfaces (2009) 0.79
Engineering the cellular protein secretory pathway for enhancement of recombinant tissue plasminogen activator expression in Chinese hamster ovary cells: effects of CERT and XBP1s genes. J Microbiol Biotechnol (2013) 0.79
A novel accurate amplification created restriction site method for determination of the wild type and the precore mutant hepatitis B virus variants. J Virol Methods (2005) 0.79
A DNA vaccine-encoded nucleoprotein of influenza virus fails to induce cellular immune responses in a diabetic mouse model. Clin Vaccine Immunol (2010) 0.79
Immunogenicity of a new HIV-1 DNA construct in a BALB/c mouse model. Iran J Immunol (2009) 0.78
Proteome modifications of juvenile beluga (Huso huso) brain as an effect of dietary methylmercury. Comp Biochem Physiol Part D Genomics Proteomics (2009) 0.78
Development of oligoclonal nanobodies for targeting the tumor-associated glycoprotein 72 antigen. Mol Biotechnol (2013) 0.78
Topical WIN55212-2 alleviates intraocular hypertension in rats through a CB1 receptor mediated mechanism of action. J Ocul Pharmacol Ther (2008) 0.78
An Accurate Confirmation of Human Immunodeficiency Virus Type 1 (HIV-1) and 2 (HIV-2) Infections with a Dot blot assay Using Recombinant p24, gp41, gp120 and gp36 Antigens. Int J Med Sci (2004) 0.77
T cells expressing VHH-directed oligoclonal chimeric HER2 antigen receptors: towards tumor-directed oligoclonal T cell therapy. Biochim Biophys Acta (2013) 0.76
Concentrations of nitric oxide metabolites in the serum of Iranian multiple sclerosis patients. J Neurol Sci (2010) 0.76
Quantification of human cytomegalovirus DNA by a new capture hybrid polymerase chain reaction enzyme-linked immunosorbent assay in plasma and peripheral blood mononuclear cells of bone marrow transplant recipients. Exp Clin Transplant (2008) 0.76
Design of Small Molecules with HIV Fusion Inhibitory Property Based on Gp41 Interaction Assay. Avicenna J Med Biotechnol (2013) 0.75
Influenza virus hemagglutinin: a model for protein N-glycosylation in recombinant Escherichia coli. Intervirology (2011) 0.75
Periplasmic Expression of a Novel Human Bone Morphogenetic Protein-7 Mutant in Escherichia coli. Avicenna J Med Biotechnol (2012) 0.75
Gait analysis of anterior cruciate ligament reconstructed subjects with a combined tendon obtained from hamstring and peroneus longus. Knee (2013) 0.75
Characterization of immune responses induced by combined clade-A HIV-1 recombinant adenovectors in mice. Iran J Immunol (2010) 0.75
Expression of a novel chimeric-truncated tPA in Pichia pastoris with improved biochemical properties. Mol Biotechnol (2014) 0.75
Evaluation of a new dot blot assay for confirmation of human immunodeficiency virus type 1 and 2 infections using recombinant p24, gp41, gp120 and gp36 antigens. Saudi Med J (2006) 0.75
Indeterminate human immunodeficiency virus western blot results in Iranian patients with discordant screening assay results. Saudi Med J (2006) 0.75
Comparison of topical and intravenous administration of WIN 55-212-2 in normotensive rabbits. Curr Eye Res (2008) 0.75
Densitometric analysis of Dot blot assays for human immunodeficiency virus type 1 and 2 antibodies. Saudi Med J (2006) 0.75
Serum cytokines profiles in Iranian patients with preeclampsia. Iran J Immunol (2007) 0.75